Skip to main content

and
  1. No Access

    Article

    Evaluating the clinical effectiveness of autologous haematopoietic stem cell transplantation versus disease-modifying therapy in multiple sclerosis using a matching-adjusted indirect comparison: an exploratory study from the Autoimmune Diseases Working Party (ADWP) of the European Society of Bone and Marrow Transplantation (EBMT)

    P. Tappenden, Y. Wang, B. Sharrack, J. Burman, M. Kazmi in Bone Marrow Transplantation (2020)

  2. No Access

    Article

    Autologous hematopoietic stem cell transplantation for pediatric multiple sclerosis: a registry-based study of the Autoimmune Diseases Working Party (ADWP) and Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT)

    Autologous hematopoietic stem cell transplantation (aHSCT) is a promising therapy for multiple sclerosis (MS), which has mainly been used in adults. The purpose of this study was to investigate efficacy and ad...

    J Burman, K Kirgizov, K Carlson, M Badoglio, G L Mancardi in Bone Marrow Transplantation (2017)

  3. No Access

    Article

    Onset and outcome of pregnancy after autologous haematopoietic SCT (AHSCT) for autoimmune diseases: a retrospective study of the EBMT autoimmune diseases working party (ADWP)

    Autologous haematopoietic SCT (AHSCT) is increasingly used to control severe and refractory autoimmune diseases (AD). Many patients are women of reproductive age with a potential desire for children. We presen...

    E Snarski, J A Snowden, M C Oliveira, B Simoes, M Badoglio in Bone Marrow Transplantation (2015)